EconBiz - Find Economic Literature
    • Logout
    • Change account settings
  • EN 
    • DE
    • ES
    • FR
  • A-Z
  • Beta
  • About EconBiz
  • News
  • Thesaurus (STW)
  • Research Skills
  • Help
  • EN 
    • DE
    • ES
    • FR
  •  My account 
    • Logout
    • Change account settings
  • Login
Publications Events
Search options
Advanced Search history
My EconBiz
Favorites Loans Reservations Fines
    You are here:
  • Home
  • Search: subject_exact:"Pharmaceutical industry"
Narrow search

Narrow search

Year of publication
Subjects
All
Pharmaceutical industry 3,083 Pharmaindustrie 2,936 USA 643 United States 625 Pharmazeutische Industrie 528 Deutschland 465 Germany 436 Arzneimittel 352 Pharmaceuticals 330 Innovation 296 India 282 Indien 264 Arzneimittelmarkt 255 Welt 249 World 249 pharmaceutical industry 224 Industrieforschung 222 Industrial research 221 Pharmaceutical market 219 Pharmakologie 207 Pharmacology 204 Theorie 188 Theory 188 Multinationales Unternehmen 184 Innovationsmanagement 166 Transnational corporation 163 Innovation management 151 Biotechnology industry 148 Biotechnologie-Industrie 144 Patent 128 Marketing 111 Gesundheitswesen 107 EU countries 105 EU-Staaten 105 Großbritannien 102 Marketing management 102 Marketingmanagement 102 Chemieindustrie 101 Chemical industry 99 United Kingdom 97
more ... less ...
Online availability
All
Free 453 Undetermined 155
Type of publication
All
Article 2,019 Book / Working Paper 1,619 Journal 63 Other 6
Type of publication (narrower categories)
All
Article in journal 1,266 Aufsatz in Zeitschriften 1,266 Graue Literatur 604 Non-commercial literature 604 Article in book 565 Aufsatz im Buch 565 Working Paper 342 Arbeitspapier 332 Thesis 253 Dissertation 245 Hochschulschrift 220 Case study 197 Fallstudie 197 Collection of articles of several authors 149 Sammelwerk 149 Dissertation u.a. Prüfungsschriften 56 Amtsdruckschrift 52 Government document 52 Bibliographie enthalten 44 Bibliography included 44 Congress report 33 Kongressschrift 33 Business report 31 Geschäftsbericht 31 No longer published / No longer aquired 28 Market information 20 Marktinformation 20 Aufsatzsammlung 19 Collection of articles written by one author 18 Sammlung 18 Kongress 15 Bibliographie 14 Company information 13 Firmeninformation 13 Statistik 12 Lehrbuch 11 Statistics 11 Advisory report 9 Gutachten 9 Reprint 8
more ... less ...
Language
All
English 2,345 German 795 Undetermined 367 French 91 Spanish 36 Italian 34 Russian 13 Portuguese 11 Hungarian 6 Polish 5 Croatian 3 Dutch 3 Swedish 3 Arabic 1 Danish 1 Finnish 1 Japanese 1 Norwegian 1 Romanian 1 Slovenian 1 Turkish 1 Ukrainian 1
more ... less ...
Persons
All
Rudholm, Niklas 23 Pammolli, Fabio 22 Riccaboni, Massimo 22 Danzon, Patricia Munch 17 Orsenigo, Luigi 17 Grabowski, Henry G. 16 Phlippen, Sandra 16 Harms, Fred 15 Cockburn, Iain 14 Gehl Sampath, Padmashree 13 Berndt, Ernst R. 12 Ahlert, Dorothee 11 Mahlich, Jörg C. 11 Nicholson, Sean 11 Preuß, Klaus-Jürgen 11 Scherer, Frederic M. 11 Vernon, John A. 11 Braun, Andreas 10 Henderson, Rebecca 10 Kale, Dinar 10 Cassel, Dieter 9 Cool, Karel O. 9 Fischer, Marc 9 Gambardella, Alfonso 9 Lakdawalla, Darius 9 Mazzucato, Mariana 9 Adelhelm, Silvia 8 Higgins, Matthew J. 8 Le Pen, Claude 8 Lichtenberg, Frank R. 8 Magazzini, Laura 8 Philipson, Tomas J. 8 Scott Morton, Fiona 8 Styhre, Alexander 8 Azoulay, Pierre 7 Bauer, Hans H. 7 Ecker, Thomas 7 Granlund, David 7 Howells, Jeremy 7 Kyle, Margaret K. 7
more ... less ...
Institutions
All
eSocialSciences 14 Volkswirtschaftliche Fakultät, Ludwig-Maximilians-Universität München 11 United Nations University-Maastricht Economic Research Institute of Innovation and Technology (UNU-MERIT) 10 Bundesverband der Pharmazeutischen Industrie 8 Université Paris-Dauphine (Paris IX) 7 Department of Economics and Business, Universitat Pompeu Fabra 6 Europäische Kommission 6 United Nations University, Maastricht Economic and social Research and training centre on Innovation and Technology 6 Verband Forschender Arzneimittelhersteller 6 Springer Fachmedien Wiesbaden GmbH 5 American Enterprise Institute for Public Policy Research 4 Institutionen för Nationalekonomi, Umeå Universitet 4 Interpharma 4 Medizinisch-Pharmazeutische Studiengesellschaft 4 Centre for Health Economics, Department of Economics and Related Studies 3 Centre for Innovation, Research and Competence in the Learning Economy (CIRCLE), Lunds Universitet 3 Department of Economics and Finance, College of Business and Economics 3 Economics Group, Business School 3 Economics, Markets, Institutions, IMT Lucca Institute for Advanced Studies 3 HAL 3 Handelns Utredningsinstitut (HUI Research) 3 Institutionen för Nationalekonomi <Ume°a> 3 International Monetary Fund (IMF) 3 Research Institute for Economics and Business Administration, Kobe University 3 Schering Aktiengesellschaft 3 Science and Technology Policy Research (SPRU), School of Business, Management and Economics 3 Tinbergen Institute 3 Tinbergen Instituut 3 UNIDO 3 United Nations University, Institute for New Technologies 3 WestLB Panmure <London ; Düsseldorf> 3 Ashridge 2 Boston College / Department of Economics 2 Byrne ÓCléirigh Limited <Dublin> 2 Center for Economic and Policy Research (CEPR) 2 Centro Studi Investimenti Sociali <Rom> 2 Christoph Merian Verlag 2 Competence Center E-Commerce <Bochum> 2 Economists Advisory Group 2 Elinkeinoelämän Tutkimuslaitos 2
more ... less ...
Published in...
All
Working paper 68 Research policy : policy, management and economic studies of science, technology and innovation 29 Journal of medical marketing 28 International journal of pharmaceutical and healthcare marketing : IJPHM 27 PharmacoEconomics 27 International journal of technology management : IJTM 21 Pharmamarketing : gesundheitsökonomische Aspekte einer innovativen Industrie am Beispiel von Deutschland, Österreich und der Schweiz 21 Technology analysis & strategic management 20 Industrial and corporate change 18 Journal of health economics 17 Gabler Edition Wissenschaft 16 R & D management 16 International journal of the economics of business 15 Journal of business ethics : JOBE 15 Innovation and marketing in the pharmaceutical industry : emerging practices, research, and policies 14 Working Papers / eSocialSciences 14 Health marketing quarterly 13 Indian pharmaceutical industry : strategies and challenges in formulations marketing 13 Journal of research in pharmaceutical economics 13 Handbuch Market-Access : Marktzulassung ohne Nebenwirkungen 12 Organization science : a journal of the Institute for Operations Research and the Management Sciences : bridging disciplines to advance knowledge of organizations 12 Pharmamarketing : ein Leitfaden für die tägliche Praxis 12 The journal of world intellectual property 12 Der pharmazeutische Betrieb 11 Europäische Hochschulschriften 11 Handbuch Direktverträge : nachhaltige Vertragsstrategien im Gesundheitswesen 11 MPRA Paper 11 Managerial and decision economics : MDE ; the international journal of research and progress in management economics 11 Pharmaceutical markets and insurance worldwide 11 Strategic management journal 11 Leadership and management in pharmacy practice 10 Management science : journal of the Institute for Operations Research and the Management Sciences 10 Pharmaceutical project management 10 Academy of Management journal : AMJ 9 Health affairs 9 The European journal of health economics : HEPAC : health economics in prevention and care 9 Applied economics 8 Faculty & research / Insead : working paper series 8 Gesundheitsmegamarkt Indien : Sourcing-, Produktions- und Vermarktungsstrategien 8 Journal of Business Ethics 8
more ... less ...
Sources
All
ECONIS (ZBW) 3,088 RePEc 354 USB Cologne (EcoSocSci) 219 BASE 25 EconStor 17 ArchiDok 4
Showing 1 - 50 of 3,707
Cover Image
Asymmetric information in the regulation of the access to markets
Ghislandi, Simone; Kuhn, Michael - 2016
Saved in:
Cover Image
What do patent-based measures tell us about product commercialization? : evidence from the pharmaceutical industry
Wagner, Stefan - 2015
Patent-based measures are frequently used as indicators in empirical research on innovation and technological change. Currently, there is little evidence as to what extent patent-based indicators relate to product market outcomes. Using a unique dataset that links outcomes from product...
Saved in:
Cover Image
Optimal incentives for patent challenges in the pharmaceutical industry
Böhme, Enrico; Frank, Jonas Severin; Kerber, Wolfgang - 2017
Since the patent system relies on private litigation for challenging weak patents, and patent settlements might influence the incentives for challenging patents, the question arises whether the antitrust assessment of patent settlements should also consider their impact on the incentives to...
Saved in:
Cover Image
Secondary pharmaceutical patenting : a global perspective
Sampat, Bhaven N.; Shadlen, Kenneth C. - 2017
Saved in:
Cover Image
Türk sağlık saktöründe tadarik zinciri yönetimine genel bir bakış
Acar, Zafer; Buk, Tuba Bozaykut - In: International Journal of Research in Business and … 6 (2017) 5, pp. 13-27
Saved in:
Cover Image
Entry and patents : evidence form the US cardiovascular pharmaceutical sector
DiIorio, Francesca; Giorgetti, Maria Letizia - 2017
Saved in:
Cover Image
Impact of mergers and acquisitions on firms' export competitiveness : experience of Indian pharmaceutical industry
Mishra, Pulak; Jaiswal, Neha - In: South Asia economic journal : journal of the Institute … 18 (2017) 1, pp. 1-20
Saved in:
Cover Image
Challenging the dominant logic in the healthcare industry : the case of precision medicine
Song, Chie Hoon - In: Technology analysis & strategic management 29 (2017) 8, pp. 843-856
Saved in:
Cover Image
The impact of R&D cooperations on drug variety offered on the market : evidence from the pharmaceutical industry
Banerjee, Tannista; Siebert, Ralph - 2014
Our study puts special attention to the fact that R&D cooperations in the pharmaceutical industry are formed at different stages throughout the drug development process. We study if the timing to engage in R&D cooperations in the pharmaceutical industry has different impacts on the technology...
Saved in:
Cover Image
What do patent-based measures tell us about product commercialization? : evidence from the pharmaceutical industry
Wagner, Stefan - 2014
Patent-based measures are frequently used as indicators in empirical research on innovation and technology as well as on firms' strategies and organizational choices to characterize inventions or, more generally, innovative activities and the technological capabilities of organizations. A clear...
Saved in:
Cover Image
Pharmaceutical regulation in Europe and its impact on corporate R&D
Eger, Stephan; Mahlich, Jörg C. - In: Health economics review 4 (2014) 23, pp. 1-9
Objectives: Many European countries regulate the markets for prescription drugs in order to cope with rising health expenditures. On the other hand, regulation distorts incentives to invest in pharmaceutical R&D. This study aims at empirically assessing the impact of regulation on pharmaceutical...
Saved in:
Cover Image
Patent settlements in the pharmaceutical industry: What can we learn from economic analysis?
Frank, Severin; Kerber, Wolfgang - 2016
Patent settlements between originator and generic firms in the pharmaceutical industry have been challenged by antitrust and competition authorities in the U.S. and the EU. Particularly settlements with large "reverse payments" to generic firms raise the concern of collusive behaviour for...
Saved in:
Cover Image
Globally dangerous diseases: Bad news for Main Street, good news for Wall Street?
Donadelli, Michael; Kizys, Renatas; Riedel, Max - 2016
This paper examines whether investor mood, driven by World Health Organization (WHO) alerts and media news on globally dangerous diseases, is priced in pharmaceutical companies' stocks in the United States. We concentrate on irrational investors who buy and sell pharmaceutical companies' stocks...
Saved in:
Cover Image
Advertising, competition, and regulation in the pharmaceutical industry
Suppliet, Moritz - 2016
Saved in:
Cover Image
Are settlements in patent litigation collusive? : evidence from paragraph IV challenges
Helland, Eric; Seabury, Seth A. - 2016
Saved in:
Cover Image
Parallel trade of pharmaceuticals : the Danish market for statins
Méndez, Susan J. - 2016
Preview
Preview
Saved in:
Cover Image
Realizing corporate responsibility : positioning and framing in nascent institutional change
Girschik, Verena C. - 2016 - 1st edition
Preview
Preview
Saved in:
Cover Image
How mergers affect innovation : theory and evidence from the pharmaceutical industry
Haucap, Justus; Stiebale, Joel - 2016
This papers analyses how horizontal mergers affect innovation activities of the merged entity and its non-merging competitors. We develop an oligopoly model with heterogeneous firms to derive empirically testable implications. Our model predicts that a merger is more likely to be profitable in...
Preview
Preview
Saved in:
Cover Image
Patent settlements in the pharmaceutical industry : what can we learn from economic analysis?
Frank, Jonas Severin; Kerber, Wolfgang - 2016
Patent settlements between originator and generic firms in the pharmaceutical industry have been challenged by antitrust and competition authorities in the U.S. and the EU. Particularly settlements with large "reverse payments" to generic firms raise the concern of collusive behaviour for...
Saved in:
Cover Image
Cost-sharing and drug-pricing strategies : introducing tiered co-payments in reference price markets
Suppliet, Moritz; Herr, Annika - 2016
Saved in:
Cover Image
Contract manufacturing and quality risk : theory and empirical evidence
Gray, John V.; Roth, Aleda V.; Tomlin, Brian - 2016
Saved in:
Cover Image
A Ricardian-demand explanation for changing pharmaceutical R&D productivity
Pauly, Mark V.; Myers, Kyle - 2016
Saved in:
Cover Image
Globally dangerous diseases : bad news for Main Street, good news for Wall Street?
Donadelli, Michael; Kizys, Renatas; Riedel, Max - 2016
This paper examines whether investor mood, driven by World Health Organization (WHO) alerts and media news on globally dangerous diseases, is priced in pharmaceutical companies' stocks in the United States. We concentrate on irrational investors who buy and sell pharmaceutical companies' stocks...
Saved in:
Cover Image
Innovation and the global expansion of intellectual property rights : unfulfilled promises
Correa, Carlos María - 2016
Saved in:
Cover Image
Determinants of pharmaceutical industry’s performance in Nigeria
Isola, Wakeel A.; Mesagan, Ekundayo Peter - In: Managing global transitions : international research journal 14 (2016) 3, pp. 267-282
This study focused on the relationships among market structure, efficiency and performance of the Nigerian Pharmaceutical industry. It employed market share and operational efficiency to determine the efficiency of the industry, pre-tax return on asset to measure performance, Herfindahl-...
Saved in:
Cover Image
Quality as the foundation for excellence : insights from the pharmaceutical industry
Mänder, Christian - 2016
Saved in:
Cover Image
Mergers and acquisitıons in pharmaceutical industry as a growth strategy : an investigation upon practice
Çilhoroz, Yasin; Sonǧur, Cuma; Gözlü, Mehmet; … - In: International journal of business & management : IJoBM 4 (2016) 3, pp. 1-12
Saved in:
Cover Image
Profitability determinants in Indian drugs and pharmaceutical industry : an analysis of pre and post TRIPS period
Tyagi, Shilpi; Nauriyal, D. K. - In: Eurasian journal of business and economics : EJBE 9 (2016) 17, pp. 1-21
Saved in:
Cover Image
Entry and patenting in the pharmaceutical industry
Giorgetti, Maria Letizia; Mancusi, Maria Luisa - 2016
Saved in:
Cover Image
Patents and R&D expenditure effects on equity returns in pharmaceutical industry
Feyzrakhmanova, Martina; Gurdgiev, Constantin - In: Applied economics letters 23 (2016) 4/6, pp. 278-283
Saved in:
Cover Image
Can prospect theory predict the decision making by professionals? : evidence from the pharmaceutical industry
Yilmaz, Neslihan; Kalaycioglu, Can - In: International journal of applied behavioral economics : … 5 (2016) 1, pp. 24-47
Saved in:
Cover Image
Physician report of industry gifts and quality of care
Lee, Doohee; Begley, Charles E. - In: Health care management review : HCM review 41 (2016) 3, pp. 275-283
Saved in:
Cover Image
Functionality of turnover intention and management strategies for sales force : an empirical investigation
Sanjeev, M. A.; Abidi, Naseem; Surya, A. V. - In: International journal of management practice : IJMP 9 (2016) 1, pp. 24-39
Saved in:
Cover Image
Technological capability building in the Brazilian pharmaceutical industry
Torres, Ricardo Lobato; Hasenclever, Lia - In: Latin American business review : journal of the … 17 (2016) 3, pp. 223-244
Saved in:
Cover Image
France's pharmaceutical industry in global value chains
Cezar, Rafael - In: Banque de France bulletin 44 (2016/17), pp. 51-63
Saved in:
Cover Image
Pharmaceutical knowledge management : why does pharmaceutical industry need knowledge management?
Mohamed, Elham Elshafie - In: International journal of knowledge management studies : … 7 (2016) 3/4, pp. 288-304
Saved in:
Cover Image
Food, health and the knowledge economy : the state and intellectual property in India and Brazil
Muzaka, Valbona - 2018
Preview
Preview
Saved in:
Cover Image
Pharma-Einkauf : qualitätsorientierte Prozesse – rechtliche Rahmenbedingungen – Trends
Bergmann, Andreas - 2018
Preview
Preview
Saved in:
Cover Image
Erfolgreich im Pharma-Marketing : wie Sie Ärzte, Apotheker, Patienten, Experten und Manager als Kunden gewinnen
Umbach, Günter - 2018 - 3. aktualisierte und erweiterte Auflage
Preview
Preview
Saved in:
Cover Image
Exploring the rise of big pharma : a French-inspired model for the global vaccine industry
Yongue, Julia S. - In: Industries and global competition : a history of …, (pp. 91-109). 2018
Saved in:
Cover Image
Pay-for-Delay-Vereinbarungen im transatlantischen Vergleich : die kartellrechtliche Beurteilung von Patent-Vergleichsvereinbarungen in der Pharmabranche anhand von Art. 101 AEUV un...
Langguth, Juliane - 2018 - 1. Auflage
Preview
Preview
Saved in:
Cover Image
Korruption im Gesundheitswesen : zur Strafbarkeit von Ärzten bei Kontakten mit der Arzneimittel- und Medizinprodukteindustrie de lege lata und de lege ferenda
Reinhardt, Katharina - 2018
Preview
Preview
Saved in:
Cover Image
What do patent-based measures tell us about product commercialization? Evidence from the pharmaceutical industry
Wagner, Stefan; Wakeman, Simon - 2015
Patent-based measures are frequently used as indicators in empirical research on innovation and technological change. Currently, there is little evidence as to what extent patent-based indicators relate to product market outcomes. Using a unique dataset that links outcomes from product...
Saved in:
Cover Image
The European Pharmaceutical Industry in a Global Economy: what drives EU exports of pharmaceuticals?
Blanc, Ludivine - European Economic Studies, College of Europe - 2015
The pharmaceutical industry is one of the most competitive sectors in the European Union. With its substantial investments in research and development, this industry represents a key asset for the European economy and a major source of growth and employment. However, despite the importance of...
Saved in:
Cover Image
Pharma-Markt Schweiz
Interpharma - Basel : Interpharma - 22. Auflage (2015) [?]-
Saved in:
Cover Image
Competition between originators and generics: public regulation and incentives to innovate
Campion, Marie-Geneviève - 2015
The aim of this thesis is to examine the competition patterns that exist between originators and generics by focusing on the articulations between regulation and incentives to innovate. Once the characteristics of regulation in pharmaceutical markets is reviewed in the first chapter and an...
Saved in:
Cover Image
Private versus social incentives for pharmaceutical innovation
González, Paula; Macho-Stadler, Inés; … - 2015
Saved in:
Cover Image
Indonesian marine biodiversity as a sustainable resource to support Indonesian pharmaceutical industry in ASEAN pharmaceutical market
Riandy, Andika Putra; Handayani, Alvionita - In: The international journal of management science and … (2015) 18, pp. 20-24
Indonesian waters are known as mega-diversity resource which can produce many chemical compounds. These compounds have been identified could be a sustainable source for novel drugs, especially for the usage of pharmaceutical. Up to 2007, at least 77 new compounds are from 14 sponges and 19 new...
Saved in:
Cover Image
Operational excellence in the pharmaceutical industry : an architecture for emerging markets
Bellm, Daniel - 2015
Saved in:
Cover Image
Innovations at the boundaries of sectoral systems of innovation and production : a study of the pharmaceutical industry
Sandner, Thilo - 2015
Saved in:
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • Next
A service of the
zbw
Questions? Chat with us

Questions? Chat with us

Loading...
 Searching for statistics or facts?
  • Sitemap
  • Contact us
  • Imprint
  • Privacy

Loading...